COMPANY

GelSana Therapeutics

Keywords: From press sources:hydrogel diabetic foot ulcer controlled release drug delivery

Location: Aurora, CO · source · Oct 14, 2026

Profile checked Oct 10, 2026

NIH awards 2

Annual award amounts. Total $625K.

Sep 5, 2024 NIH award 1R43DK141293-01 FY2024: $324,992 awarded for that fiscal year; activity R43 (SBIR); PI ROCKER, ADAM; recipient as written: GELSANA THERAPEUTICS, INC., AURORA, CO. Advancing Diabetic Foot Ulcer Treatment wit source ↗
Apr 24, 2023 NIH award 1R43DK134283-01A1 FY2023: $299,650 awarded for that fiscal year; activity R43 (SBIR); PI ROCKER, ADAM; recipient as written: GELSANA THERAPEUTICS, INC., AURORA, CO. Topical Drug Delivery System as an Anti-I source ↗

Raise Seed · amount not disclosed · announced Nov 30, 2023 Company release ↗
Source quote
- Nov 30, 2023 · Company release ↗
  “GelSana Announces Initial Close on Second Seed Priced Round”

From the company’s own releases; this list is partial. All raises and deals